Scotia Capital’s Pediatrix Medical MD Stock Holding History

Scotia Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,634	Closed	-$206K	–	958
2025 Q4	$206K	Buy	+9,634	New	+$197K	﹤0.01%	846

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Scotia Capital's MD Position: Q1 2026 in Review

Scotia Capital sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 9,634 shares — an estimated $206K sold.

Scotia Capital first reported a position in MD in Q4 2025 and held it in 1 quarter. The position peaked at $206K in Q4 2025. 297 funds tracked by Wall St. Rank hold MD as of Q1 2026.

Scotia Capital reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
Scotia Capital sold 9,634 Pediatrix Medical shares in Q1 2026, an estimated $206K.
Scotia Capital first reported a position in Pediatrix Medical in Q4 2025 and held it in 1 quarter.
Scotia Capital's Pediatrix Medical position peaked at $206K in Q4 2025.
297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.